United States (US) Oral Antiviral Market (2025-2031) | Industry, Growth, Segmentation, Analysis, Outlook, Competitive Landscape, Forecast, Trends, Size & Revenue, Value, Share, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oral Antiviral Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oral Antiviral Market - Industry Life Cycle

3.4 United States (US) Oral Antiviral Market - Porter's Five Forces

3.5 United States (US) Oral Antiviral Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United States (US) Oral Antiviral Market Revenues & Volume Share, By Drug class, 2021 & 2031F

3.7 United States (US) Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of viral infections such as herpes, influenza, and HIV in the US

4.2.2 Growing awareness about the effectiveness of oral antiviral drugs in treating viral infections

4.2.3 Technological advancements in the development of oral antiviral medications

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval of oral antiviral drugs

4.3.2 Competition from generic drug manufacturers impacting pricing and market share

4.3.3 Potential side effects associated with long-term use of oral antiviral medications

6.1 United States (US) Oral Antiviral Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United States (US) Oral Antiviral Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United States (US) Oral Antiviral Market Revenues & Volume, By Hepatitis, 2021- 2031F

6.1.4 United States (US) Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021- 2031F

6.1.5 United States (US) Oral Antiviral Market Revenues & Volume, By Influenza, 2021- 2031F

6.1.6 United States (US) Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Oral Antiviral Market, By Drug class

6.2.1 Overview and Analysis

6.2.2 United States (US) Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2021- 2031F

6.2.3 United States (US) Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F

6.2.4 United States (US) Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Oral Antiviral Market, By Distribution channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F

6.3.3 United States (US) Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2021- 2031F

6.3.4 United States (US) Oral Antiviral Market Revenues & Volume, By Online providers, 2021- 2031F

7.1 United States (US) Oral Antiviral Market Export to Major Countries

7.2 United States (US) Oral Antiviral Market Imports from Major Countries

8.1 Rate of new viral infections reported in the US

8.2 Number of prescriptions for oral antiviral drugs issued by healthcare providers

8.3 Research and development investment in new oral antiviral drug formulations

9.1 United States (US) Oral Antiviral Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United States (US) Oral Antiviral Market Opportunity Assessment, By Drug class, 2021 & 2031F

9.3 United States (US) Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2021 & 2031F

10.1 United States (US) Oral Antiviral Market Revenue Share, By Companies, 2024

10.2 United States (US) Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters